Skip to content
by Legal Desire
19 February 2025

Latham & Watkins Advises Arcus Biosciences in US$150 Million Offering of Common Stock

Advising firms

Deal team

16 lawyers named
LawyerFirmSeniorityPracticeOffice
Mark Roeder Lead Latham & Watkins LLP Partner corporate Bay Area
John Williams Lead Latham & Watkins LLP Partner corporate Bay Area
Caitlin Nguyen Latham & Watkins LLP Associate corporate Not stated
Chelsi DeTurk Latham & Watkins LLP Associate corporate Not stated
Kelsey MacKinnon Latham & Watkins LLP Associate corporate Not stated
Christopher Hazuka Latham & Watkins LLP Partner intellectual property San Diego/Bay Area
Robert Yeh Latham & Watkins LLP Counsel intellectual property San Diego
Kristina Funahashi Latham & Watkins LLP Associate intellectual property Not stated
Elizabeth Richards Latham & Watkins LLP Partner regulatory Washington, D.C.
Betty Pang Latham & Watkins LLP Partner regulatory Bay Area
Chad Jennings Latham & Watkins LLP Counsel regulatory Washington, D.C.
Evan Miller Latham & Watkins LLP Associate regulatory Not stated
Kirt Switzer Latham & Watkins LLP Partner tax Bay Area
Grace Lee Latham & Watkins LLP Partner tax Bay Area
Alphonse Simon Latham & Watkins LLP Associate tax Not stated
Jay Metz Latham & Watkins LLP Partner compensation and benefits Bay Area

13 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.

REGISTER FREE SIGN IN

Want co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.

Stated terms

Stated value
USD 150m (US$150 million)
What the figure measures
Issue size
Client
Arcus Biosciences, Inc.Issuer
Counterparties
Not stated